|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
94a Innovation Drive, Milton Park, Abingdon, GB
|
|
Oxford BioTherapeutics is an international biotechnology company focused on developing innovative antibody therapies to treat cancer. This new treatment approach combines a number of technologies to target cancer cells with potent cell-killing agents. Our OGAPĀ® target discovery system provides a unique range of validated, novel antigen targets identified from a wide range of cancer types.
We are now advancing our portfolio of treatments into clinical testing with our development partner Menarini. In addition to this in-house ADC development, we also work with pharmaceutical companies to provide our target discovery expertise as the foundation for new cancer therapies.
Company Leadership
Christian Rohlff, CEO
Scott Sandler, VP, Finance & Operations
Tom Boone, VP, Protein Sciences
|
Oxford BioTherapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{l} | [email protected] |
100%
|
The widely used Oxford BioTherapeutics email format is {first}.{l} (e.g. [email protected]) with 100% adoption across the company.
To contact Oxford BioTherapeutics customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.